Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Market Cap	$1.78B	P/E Ratio	15.03
52W High	$46.42	52W Low	$16.16
Div Yield	48.0%	Payout Ratio	273.8%
EPS Growth 3Y	-0.5%	52W Position	84.2%
Overall Score	72	Value Score	90
Quality Score	--	Technical Score	54

EPS Current Est	$2.77	EPS Next Est	$2.9
EPS Growth Est	+4.7%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PAHC	$41.63	+2.01%	271.67K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PAHC	$41.63	+2.0%	271.67K
3
4
5
6

PAHC

PAHC

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Phibro Animal Health Corporation Data in Excel

Get Phibro Animal Health Corporation Data in Excel